Lv11
40 积分 2023-09-07 加入
Relationship between Serum Leptin, Lipid Metabolism, HbA1c, and Renal Function in Individuals with Type 2 Diabetes Mellitus and Obesity and in Individuals with Type 2 Diabetes Mellitus without Obesity
5小时前
待确认
Residual cardiovascular risk: When should we treat it?
1个月前
已完结
Dapagliflozin in Myocardial Infarction without Diabetes or Heart Failure
1个月前
已完结
Effects of empagliflozin on lipoprotein subfractions in patients with type 2 diabetes: data from a randomized, placebo-controlled study
1个月前
已完结
Association of High-Density Lipoprotein Parameters and Risk of Heart Failure
1个月前
已完结
Metabolic changes induced by dapagliflozin, an SGLT2 inhibitor, in Japanese patients with type 2 diabetes treated by oral anti-diabetic agents: A randomized, clinical trial
1个月前
已完结
Effects of empagliflozin on lipoprotein subfractions in patients with type 2 diabetes: data from a randomized, placebo-controlled study
1个月前
已完结
Comparison of coronary atherosclerotic features in response to achieving LDL-C <55 mg/dl between non-diabetic and diabetic patients: insights from the REASSURE-NIRS registry
3个月前
已完结
Management of diabetic dyslipidemia: Navigating the new American and European Guidelines
3个月前
已完结
Residual cardiovascular risk: When should we treat it?
3个月前
已完结
皖公网安备34019202002308
